Artificial Intelligence-Based Diets: A Role in the Nutritional Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease?

被引:0
|
作者
Karahan, Tugce Ozlu [1 ]
Kenger, Emre Batuhan [1 ]
Yilmaz, Yusuf [2 ]
机构
[1] Istanbul Bilgi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Istanbul, Turkiye
[2] Recep Tayyip Erdogan Univ, Sch Med, Dept Gastroenterol, Rize, Turkiye
关键词
artificial intelligence; ChatGPT; guideline recommendations; metabolic dysfunction-associated steatotic liver disease; nutritional therapy; PRACTICE GUIDANCE; MANAGEMENT; ENERGY;
D O I
10.1111/jhn.70033
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern. Effective management of this condition relies heavily on lifestyle modifications and dietary interventions. In this study, we sought to evaluate the dietary plans for MASLD generated by ChatGPT (GPT-4o) according to current guideline recommendations. Methods: ChatGPT was used to create single-day meal plans for 48 simulated patients with MASLD, tailored to individual characteristics such as age, gender, height, weight and transient elastography parameters. The plans were assessed for appropriateness according to disease-specific guidelines. Results: The mean energy content of the menus planned by ChatGPT was 1596.9 +/- 141.5 kcal with a mean accuracy of 91.3 +/- 11.0%, and fibre content was 22.0 +/- 0.6 g with a mean accuracy of 88.1 +/- 2.5%. However, they exhibited elevated levels of protein, fat and saturated fat acids. Conversely, the carbohydrate content was lower. ChatGPT recommended weight loss for obese patients but did not extend this advice to normal-weight and overweight individuals. Notably, recommendations for a Mediterranean diet and physical activity were absent. Conclusions: ChatGPT shows potential in developing dietary plans for MASLD management. However, discrepancies in macronutrient distributions and the omission of key evidence-based recommendations highlight the need for further refinement. To enhance the effectiveness of AI tools in dietary recommendations, alignment with established guidelines must be improved.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Hepatic Steatosis Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Artificial Intelligence
    Wang, Xiao-Xiao
    Song, Yu-Yun
    Jin, Rui
    Wang, Zi-Long
    Li, Xiao-He
    Yang, Qiang
    Teng, Xiao
    Liu, Fang-Fang
    Wu, Nan
    Xie, Yan-Di
    Rao, Hui-Ying
    Liu, Feng
    DIAGNOSTICS, 2024, 14 (24)
  • [2] Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Polyzos, Stergios A.
    Targher, Giovanni
    CURRENT OBESITY REPORTS, 2024, 13 (02) : 242 - 255
  • [3] Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Nendouvhada, Livhuwani P.
    Sibuyi, Nicole R. S.
    Fadaka, Adewale O.
    Meyer, Samantha
    Madiehe, Abram M.
    Meyer, Mervin
    Gabuza, Kwazikwakhe B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [4] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
  • [5] The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies
    Wang, Li Jun
    Sun, Jian Guang
    Chen, Shu Cheng
    Sun, Yu Li
    Zheng, Yang
    Feng, Jian Chao
    FRONTIERS IN MEDICINE, 2025, 11
  • [6] Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Maher, Salim
    Rajapakse, Jayashi
    El-Omar, Emad
    Zekry, Amany
    SEMINARS IN LIVER DISEASE, 2024, 44 (04) : 457 - 473
  • [7] Metabolic dysfunction-associated steatotic liver disease and the heart
    Driessen, Stan
    Francque, Sven M.
    Anker, Stefan D.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    HEPATOLOGY, 2023,
  • [8] Metabolic dysfunction-associated steatotic liver disease in adults
    不详
    NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):
  • [9] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
    Castillo-Nunez, Yulino
    Almeda-Valdes, Paloma
    Gonzalez-Galvez, Guillermo
    Arechavaleta-Granell, Maria del Rosario
    CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
  • [10] Metabolic dysfunction-associated steatotic liver disease in adults
    Huang, Daniel Q.
    Wong, Vincent W. S.
    Rinella, Mary E.
    Boursier, Jerome
    Lazarus, Jeffrey V.
    Yki-Jarvinen, Hannele
    Loomba, Rohit
    NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):